FDA Inspection
RMA Long Island IVFRMA Long Island IVF – FDA Inspection, Feb 9, 2024
Record Details
This FDA Inspection record concerns RMA Long Island IVF, with an inspection on February 9, 2024, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · d3a572d3-1795-41a8-840a-52327db22793
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1229041
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
3- 21 CFR 1271.55(d)(2)Accurate, indelible, legible
- 21 CFR 1271.50(a)Responsible person to determine, document
- 21 CFR 1271.47(a)Testing, screening, donor eligibility procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of RMA Long Island IVF
7| Date | Classification | Office | Project area |
|---|---|---|---|
| March 1, 2022 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| December 13, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 20, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 16, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| January 11, 2013 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for RMA Long Island IVF
- FDA Inspection 1163524 - 2022-03-01
- FDA Inspection 1076523 - 2018-12-13
- FDA Inspection 994705 - 2016-12-20
- FDA Inspection 900033 - 2014-10-16
- FDA Inspection 813876 - 2013-01-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.